I agree. I guess some are indiscriminantly lumping IMU in with those other 1/4 of biotechs which may face financial difficulty in the coming months. Certainly this is not the case here. IMU is one of few which will run cash flow positive... a very strong position in these turbulent times. IMO DYOR
Extract from the Quarterly Report
October – December 2008 - Quarter Highlights:
-Strategic Alliance signed with Merial Limited – 31 December 2008
-Initial income totaling US$2 million (AUD$2.9 million) received on 31 December 2008
-Strategic Alliance income exceeds AUD$30 million to Imugene within next 7 years
-Additional income from further sub-license fees and milestone payments on individual products and ultimately royalties on sales
-Imugene translates recent trial successes into a solid income stream
-Cashflow positive for the half year
-Strong cash income stream from IP achieved well in advance of product sales
-Imugene now in a secure financial position moving forward
-No foreseeable need to raise further capital
- Forums
- ASX - By Stock
- IMU
- can't believe this
can't believe this, page-3
-
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
5.5¢ |
Change
0.001(1.85%) |
Mkt cap ! $395.2M |
Open | High | Low | Value | Volume |
5.5¢ | 5.6¢ | 5.2¢ | $943.1K | 17.39M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
30 | 1598266 | 5.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.5¢ | 4033254 | 22 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
29 | 1572066 | 0.054 |
30 | 2916776 | 0.053 |
26 | 2446084 | 0.052 |
25 | 3414585 | 0.051 |
73 | 4459705 | 0.050 |
Price($) | Vol. | No. |
---|---|---|
0.055 | 4031854 | 23 |
0.056 | 2788170 | 15 |
0.057 | 2279800 | 9 |
0.058 | 1367079 | 5 |
0.059 | 1125099 | 8 |
Last trade - 11.52am 28/06/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |